Experience

Boehringer Laboratories, LLC

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director of Marketing

  • Jun 2023 - Present

  For over 50 years, Boehringer Laboratories, LLC has provided expertly engineered solutions in respiratory therapy, suction controls, and minimally invasive surgery. I am building and leading all aspects of the Marketing Department including brand strategy, positioning and messaging, market research, marketing plan execution and sales team partnerships. For over 50 years, Boehringer Laboratories, LLC has provided expertly engineered solutions in respiratory therapy, suction controls, and minimally invasive surgery. I am building and leading all aspects of the Marketing Department including brand strategy, positioning and messaging, market research, marketing plan execution and sales team partnerships.



Native Cardio, Inc.

• United States
• Medical Device
• 1 - 100 Employee

• Chief Marketing Officer - Consultant

  • Jan 2023 - Jun 2023

  Led marketing strategy for a start-up US cardiovascular company preparing for the launch of a novel surgical cardiovascular device designed to restore normal sinus rhythm following post-operative atrial fibrillation. Responsibilities included developing sources of investment funding, building go-to-market strategies and devising sales channel optimization. Led marketing strategy for a start-up US cardiovascular company preparing for the launch of a novel surgical cardiovascular device designed to restore normal sinus rhythm following post-operative atrial fibrillation. Responsibilities included developing sources of investment funding, building go-to-market strategies and devising sales channel optimization.



Integra LifeSciences

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Sr. Vice President of Marketing/Chief Marketing Officer

  • Jul 2019 - Jan 2023

• Senior Vice President Marketing and Strategy

  • Apr 2017 - Jul 2019

• Vice President, Marketing and Strategy

  • May 2014 - Apr 2017

• Senior Director of Marketing and Strategy - Neurosurgery

  • Aug 2012 - May 2014



Umbria Pharmaceuticals

• Naples, FL

• Chief Commercial Officer

  • Sep 2011 - Aug 2012



Baxter International Inc.

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Vice President of Marketing

  • Sep 2007 - Jun 2011

  Drove P&L management and $15M operating budget, marketing strategies, and sales for anesthesia and cardiovascular portfolios, including Suprane, sevoflurane, and Forane (inhaled anesthetics), Brevibloc (IV beta blocker), and Transderm Scop (PONV agent). Supervised Product Management, Marketing Communications, Business Operations, and Sales Training teams. Led National Accounts Sales Team that established strategic relationships with GPO/IDN leadership, hospital pharmacies, and government… Show more Drove P&L management and $15M operating budget, marketing strategies, and sales for anesthesia and cardiovascular portfolios, including Suprane, sevoflurane, and Forane (inhaled anesthetics), Brevibloc (IV beta blocker), and Transderm Scop (PONV agent). Supervised Product Management, Marketing Communications, Business Operations, and Sales Training teams. Led National Accounts Sales Team that established strategic relationships with GPO/IDN leadership, hospital pharmacies, and government accounts. Challenge: Differentiate Suprane in the market against two low-cost U.S. sevoflurane competitors. Action: Executed a three-pronged approach: developed campaigns focusing on trust in Baxter’s products, service, and support; emphasized the predictability of rapid wake-up after surgery, allowing the OR and surgeon to schedule time and facilities more efficiently; and created a pricing structure that delivered enhanced value to clients purchasing both Suprane and sevoflurane from Baxter. Result: > Increased Suprane’s defensible market niche via “Predictable Patient Recovery” campaign. > Achieved U.S. inhaled anesthetic market-share leadership position with 57.3% dollar share in 2008. > Catapulted inhaled anesthetic revenue from $102M in 2000 to $259M in 2008. Challenge: Reposition Brevibloc’s core value proposition to capitalize on shifting marketplace perceptions of beta blocker effectiveness. Action: Focused the brand’s value specifically on the drug’s precise short term and immediate heart rate-controlling effect while simultaneously launching a dedicated cardiovascular sales team of 28 reps. Moved into critical care units as an untapped market, creating the first sustained promotion in leading cardiac centers. Result: > Delivered a 17% growth rate over the previous year.

• Senior Director of Marketing

  • Aug 2005 - Sep 2007

  Managed P&L for inhaled anesthetic portfolio, Brevibloc, and Transderm Scop. Conducted detailed commercial assessments of pharmaceutical acquisition and partnership opportunities. Managed staff of 15 and an operating budget of $10M. Challenge: Launch generic sevoflurane in the U.S., Japan, China, U.K., Australia, and New Zealand, including worldwide distribution and training in multiple languages, without eroding the market for in-house brand Suprane. Action: Led… Show more Managed P&L for inhaled anesthetic portfolio, Brevibloc, and Transderm Scop. Conducted detailed commercial assessments of pharmaceutical acquisition and partnership opportunities. Managed staff of 15 and an operating budget of $10M. Challenge: Launch generic sevoflurane in the U.S., Japan, China, U.K., Australia, and New Zealand, including worldwide distribution and training in multiple languages, without eroding the market for in-house brand Suprane. Action: Led multidisciplinary global teams in all pre-launch and launch activities including regulatory approval, product positioning, branding, promotional material development, product pricing strategy, packaging, sales representative training, and distribution. Implemented a profitable market-share growth strategy for inhaled anesthetics. Led Vaporizer Management Team in anesthesia revenue maximization from deployed capital assets. Result: > Delivered $58.6M in incremental revenue in year one, while also increasing Suprane revenue by $36.6M. > Secured more than 2,100 inhaled anesthetic contracts with only 1% annual customer loss.

• Director of Marketing

  • May 2004 - Aug 2005

  Directed P&L responsibility for annual revenue of $198M and a $10M operating budget. Led four high-profile marketing teams in anesthesia, cardiology, and PONV therapeutics. Managed five Product Managers and three Marketing Communication Managers. Challenge: Resegment the U.S. inhaled anesthetic marketplace in anticipation of releasing generic sevoflurane in direct competition with premium Suprane. Action: Utilized market research that indicated Suprane’s fat solubility was a… Show more Directed P&L responsibility for annual revenue of $198M and a $10M operating budget. Led four high-profile marketing teams in anesthesia, cardiology, and PONV therapeutics. Managed five Product Managers and three Marketing Communication Managers. Challenge: Resegment the U.S. inhaled anesthetic marketplace in anticipation of releasing generic sevoflurane in direct competition with premium Suprane. Action: Utilized market research that indicated Suprane’s fat solubility was a mission-critical feature differentiating its use with the overweight patient segment. Launched patient-specific messaging and educational materials. Result: > Profitably repositioned Suprane as the inhaled anesthetic of choice for overweight patients, driving $18.9M in incremental revenue.

• Product Group Manager - Anesthesia

  • Aug 2003 - May 2004

  Led brand teams in developing the U.S. marketing strategy and tactics for Baxter’s most profitable lines. Key member of the business development team responsible for creating a co-marketing agreement with Novartis for Transderm Scop. Led three Product Managers and a $8M operating budget. Challenge: Launch new postoperative nausea/vomiting indication for Transderm Scop anti-nausea patch. Action: Translated “voice of the customer” anesthetic feedback into impactful brand messaging… Show more Led brand teams in developing the U.S. marketing strategy and tactics for Baxter’s most profitable lines. Key member of the business development team responsible for creating a co-marketing agreement with Novartis for Transderm Scop. Led three Product Managers and a $8M operating budget. Challenge: Launch new postoperative nausea/vomiting indication for Transderm Scop anti-nausea patch. Action: Translated “voice of the customer” anesthetic feedback into impactful brand messaging and new investigator-initiated clinical studies. Result: > Drove $6.3M in incremental revenue in 2004.

• Senior Product Manager - Suprane

  • Aug 2001 - Aug 2003

  Managed P&L, including a $6.5M operating budget. Supervised Associate Product Manager. Challenge: Resolve a perception that Suprane irritates the airways by educating users on proper administration. Action: Spearheaded the development and international launch of the largest medical-education endeavor ever undertaken at Baxter – The Inhaled Anesthetic Distinguished Professor Program, which was adopted by more than 80% of anesthesia teaching programs. Created well-trained… Show more Managed P&L, including a $6.5M operating budget. Supervised Associate Product Manager. Challenge: Resolve a perception that Suprane irritates the airways by educating users on proper administration. Action: Spearheaded the development and international launch of the largest medical-education endeavor ever undertaken at Baxter – The Inhaled Anesthetic Distinguished Professor Program, which was adopted by more than 80% of anesthesia teaching programs. Created well-trained speakers’ bureau of leading anesthesiologists and nurse-anesthetists who delivered in-depth training on Suprane for their peers. Result: > Grew Suprane sales by $28.7M in 2003; the highest annual growth performance since the 1994 launch. > Honored with Baxter Healthcare’s Marketing Impact Award. > Recipient of the 2001 Baxter Special Achievement Award for contributions to field sales performance.

• Product Manager - Suprane

  • Jul 2000 - Aug 2001

  Managed P&L for Suprane. Stimulated market share growth by introducing innovative peer-to-peer selling programs. Wrote and implemented the Suprane marketing plan detailing product objectives, strategies, tactics, revenue/pricing expectations, and competitor analysis. Directed the efforts of outside advertising agencies, developed monthly forecasts, led market-research projects, and tracked performance. Managed one Associate Product Manager and a $4M operating budget. Result: >… Show more Managed P&L for Suprane. Stimulated market share growth by introducing innovative peer-to-peer selling programs. Wrote and implemented the Suprane marketing plan detailing product objectives, strategies, tactics, revenue/pricing expectations, and competitor analysis. Directed the efforts of outside advertising agencies, developed monthly forecasts, led market-research projects, and tracked performance. Managed one Associate Product Manager and a $4M operating budget. Result: > Engineered the strategic repositioning of Suprane to reflect a meaningful, clinician-oriented benefit proposition that resulted in a $24M increase in 2001 revenue.



Pegasus Airwave Inc

• Boca Raton, Florida

• Executive Director of Marketing

  • Jul 1990 - Jul 2000

  Held marketing and sales positions of increasing responsibility within a global medical equipment company with annual revenue in excess of $27M. Result: > As Executive Director of Marketing, led three Product Managers in the successful launch of five prescription specialty-support surface products to the U.S. wound-care marketplace. Promoted four times. > Became the company’s first regional sales manager. > Achieved #1 sales representative status in the U.S. Held marketing and sales positions of increasing responsibility within a global medical equipment company with annual revenue in excess of $27M. Result: > As Executive Director of Marketing, led three Product Managers in the successful launch of five prescription specialty-support surface products to the U.S. wound-care marketplace. Promoted four times. > Became the company’s first regional sales manager. > Achieved #1 sales representative status in the U.S.